Introduction
Drug-induced liver injury (DILI) and cardiotoxicity remain among the leading causes of preclinical and clinical drug attrition, drug withdrawals from the marketplace and black-box warnings on marketed drugs. To mitigate the risk of organ toxicities, regulatory agencies require live animal studies before the initiation of clinical drug trials; however, the rat, which is often the rodent species chosen for drug testing, is less than 50% predictive of human DILI [1, 2] , likely due to significant variations in drug metabolism pathways across different species [3] . Similarly, rodents fail to recapitulate human cardiac physiology. For instance, mice maintain a resting heart rate approximately 10-fold higher than humans as well as a QT interval one-fourth of an average human [4] . Given the innate challenges observed with using animals for drug screening, the field of in vitro human tissue engineering has gained increasing importance over the past 10 years [5] . The utilization of technologies such as protein micropatterning, microfluidics, three-dimensional scaffolds and bioprinting has revolutionized in vitro platforms as well as increased longevity and reproducibility of cell functions.
Human cell-based models include tissue slices, microsomes, immortalized cell lines and primary cells [6] . The majority of cell-based models currently rely on immortalized cell lines obtained from human tumours. While these cell lines have their advantages, such as cost efficiency and experimental reproducibility, they do not express normal levels of primary cell functions and offer limited biological relevance [7, 8] . Organ tissue slices are only viable for a short time and are not amenable to high-throughput screening (HTS); therefore, isolated primary cells are considered the gold standard for drug screening and discovery.
However, primary cells typically undergo alterations in expressed proteins within hours after plating on conventional substrates such as collagen-coated tissue culture polystyrene plates or dishes. For example, cytochrome P450 and mitochondrial proteins in hepatocytes undergo major changes resembling de-differentiation in functional studies [9] . Furthermore, primary cells also have key disadvantages for HTS for millions of compounds due to the severely limited availability of healthy and genetically-diverse human donor organs. Nonetheless, as we demonstrate throughout this article, when cultured in the appropriate context/platform (as opposed to conventional substrates), the phenotype of primary cells can bear a greater resemblance to the organ of interest for prolonged culture periods in vitro. The rapidly advancing fields of embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC) are beginning to yield differentiated cells for downstream applications use that are more similar in their phenotype to primary cells [10] . Using iPSCs allows for reproducible cell sourcing and a genetically diverse background of cells, which is necessary for ultimately detecting idiosyncratic (unpredictable) drug toxicity in the human patient population.
In this review, we will discuss the design considerations and utility of bioengineered organ models, specifically focusing on the liver and heart, created to enable accurate prediction of clinically-relevant outcomes. We highlight representative platforms, some in commercial practice, to demonstrate major points. Finally, we discuss pending issues that will need to be addressed moving forward in the field of in vitro tissue engineering for drug screening.
Micropatterned cultures/co-cultures (a) Liver
Heterotypic interactions between parenchymal and nonparenchymal cells (NPCs) are critical in liver development, physiology and pathophysiology. In vitro co-culture with both liver and non-liver derived NPC types, such as mouse 3T3 fibroblasts [11] [12] [13] [14] , has been long known to induce functions in multiple species, most notably human [15] , which suggests that the molecular mediators underlying this 'coculture effect' are relatively well-conserved across species [16, 17] . In our experience, 3T3-J2 murine embryonic fibroblasts induce higher levels of function in primary human hepatocytes (PHHs) than liver sinusoidal endothelial cells [18] , hepatic stellate cells [19] , Kupffer cells/macrophages [20] , and human neonatal and adult dermal fibroblasts (GE Brown and SR Khetani 2017, unpublished work); this outcome is likely due to the ability of the 3T3-J2 fibroblasts to express diverse molecules present in the liver, such as decorin [21] and T-cadherin [22] , both of which have been implicated in the ability of these fibroblasts to induce functions in hepatocytes from different species. Furthermore, as we describe below, the use of 3T3-J2 fibroblasts in co-culture with primary hepatocytes does not prevent the effective use of the stabilized hepatocytes for many applications in drug development. Nonetheless, the use of two different species in a liver co-culture may be confounding for certain assays and thus we and others continue to evaluate human-specific NPCs that induce functions to a similar extent as the 3T3-J2 murine fibroblasts.
Irrespective of the type of NPC used for co-cultures, randomly dispersed co-cultures do not allow for precise and controlled modulation of homotypic and heterotypic cell-cell interactions. To engineer platforms with optimal in vivo-like conditions, precise control over extracellular matrix (ECM) protein composition, cell-cell interactions, and microenvironment geometry is required. Cellular micropatterning has emerged as a technique to explore the relationship between cell/tissue architecture and functions [23] . In the case of the liver, Bhatia et al. modified a technique from the semiconductor industry to first micropattern primary rat hepatocytes on collagen-coated circular domains and then surround the hepatocyte domains with 3T3-J2 fibroblasts [16, 24] . This technique, also known as micropatterned co-cultures (MPCCs), allowed for tuning of homotypic interactions between hepatocytes and the heterotypic interface between hepatocytes and the fibroblasts while maintaining cell numbers/ratios constant across various patterned configurations. Overall, circular domains (versus patterns with sharp corners) maintained pattern fidelity over time; hepatocyte homotypic interactions, even in the presence of fibroblast-conditioned medium, were not sufficient to rescue liver functions without physical contact with the fibroblasts; and increasing the heterotypic interface between fibroblasts and hepatocytes via a reduction in the collagen-coated domain diameter led to higher liver functions. In contrast to rat hepatocytes, Khetani et al. showed that PHHs displayed highest functions on collagen-coated domains of intermediate diameters (approximately 500 mm domain diameter with 1200 mm centre-to-centre spacing between domains), suggesting a species-specific balance in homotypic interactions between hepatocytes and their heterotypic interactions with the fibroblasts [25] (figure 1a,b). PHHs display high and stable functions in MPCCs for four to six weeks (figure 1c) as compared to an unstable phenotype observed in randomly dispersed co-cultures of the same two cell types.
Human MPCCs adapted into a multi-well format have exemplified utility in many drug development applications, such as drug clearance predictions [11, 28, 29] , drug-drug interactions [11, 25, 30, 31] , drug metabolite profiling [32] [33] [34] , drugtransporter interactions [31, 35] and DILI prediction [1, 36] ; this platform has also been used to model infection due to hepatitis B/C viruses [37, 38] and malaria [39, 40] . For example, MPCCs were treated for up to 9 days with 45 drugs of which 35 have known DILI effects in patients while 10 are generally considered non-liver toxins [1] . Given inter-individual differences in drug concentrations within the liver, MPCCs were treated with drug concentrations up to 100-fold of the reported C max (maximum drug concentration in human plasma), a common technique also used in other platforms that does not increase the false positive rate for DILI detection [41] . Repeated drug treatment for at least 9 days improved the sensitivity for DILI detection without a reduction in specificity (as assessed via adenosine triphosphate, albumin and urea). Furthermore, MPCCs showed a significantly higher sensitivity than 24 h treatment of conventional PHH monolayers with the same drugs (figure 1d). In another example, Davidson et al. introduced activated (myofibroblastic) hepatic stellate cells (HSCs) into the MPCC platform, creating a tri-culture (MPTC), towards modelling symptoms of non-alcoholic steatohepatitis (NASH) (figure 1e,f). Specifically, the addition of activated HSCs led to a significant decrease in the hepatic cytochrome-P450 enzyme (3A4, 2A6) and drug transporter activities, and a significant increase in hepatic lipid accumulation (steatosis) without affecting albumin and urea secretions (figure 1g). The inhibition of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and activation of farnesoid X receptor with clinically rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 373: 20170225 relevant drugs alleviated hepatic dysfunctions in MPTCs. The MPTC provides an in vitro model to accurately recapitulate symptoms of NASH and early fibrosis-like dysfunctions in PHHs that can be applied to drug discovery [19] .
The MPCC technology has also been adapted to induced pluripotent stem cell-derived human hepatocyte-like cells (iHeps) [10] , which allow for a sustainable approach to evaluating cell responses to drugs and other stimuli across diverse genetic backgrounds [42] . In conventional confluent monocultures, iHeps rapidly decline to an immature phenotype; however, when cultured in the MPCC platform, they display higher levels of adult-like functions, measured as a ratio of albumin (adult marker) to alpha-fetoprotein (fetal marker) over four weeks. The platform was subsequently used successfully to detect drug-mediated CYP450 induction [10] and DILI [26] .
(b) Heart
As with hepatocytes, microfabrication-based patterning techniques are employed in vitro to maintain the physiological and pathophysiological characteristics of cardiomyocytes. Cardiomyocyte alignment can be modified through surface topography [43, 44] and microcontact printing ECM proteins on non-adhesive surfaces, such as fibronectin onto alginate [45] or laminin onto polyacrylamide films [46] . In order to increase sarcomere formation and cell alignment in H9 human embryonic stem cell-derived cardiomyocytes (hESCs), Salick et al. created a microcontact printing method to pattern poly(ethylene glycol) with fibronectin [47] . A pure population of hESCs was seeded onto domains of different sizes, followed by an assessment of actin presence and nuclear alignment to determine cell direction. The domains with widths between 30 mm and 80 mm resulted in a drastic increase of sarcomere alignment. Based on the indicated maturation of hESC-derived cardiomyocytes, this allows for possible pharmacological applications. In another study, Lyra-Leite et al. monitored mitochondrial function, critical for generating ATP for intended sarcomere shortening [48] , while modulating matrix elasticity and tissue alignment [49] . Sprague-Dawley neonatal rat ventricular myocytes were seeded onto polydimethylsiloxane MPCCs created using PHHs maintain high levels of CYP450 activities for several weeks [11] . CYP3A4 activity was assessed via metabolism of testosterone into 6b-OH-testosterone, while CYP2D6 activity was assessed via metabolism of dextromethorphan into dextrorphan. (d ) Sensitivity and specificity for drug-induced hepatotoxicity prediction in Matrigel/collagen sandwich cultured PHHs (SCHH), MPCCs created using PHHs (PHH-MPCCs), and MPCCs created using iPSC-derived human hepatocyte-like cells (iMPCCs). All culture models were treated with 37 hepatotoxic drugs and 10 non-liver-toxic drugs (24-h treatment for SCHH, 9-day treatment for PHH-MPCCs and 6-day treatment for iMPCCs) to calculate the sensitivity and specificity [1, 26] . Oxygen consumption was measured to determine ATP production. The study concluded that a high elastic modulus (2686.7 + 143.6 kPa) along with isotropic aligned actin filaments led to increased mitochondrial function. Geometric confinement provided by a micropatterned substrate can also trigger self-organization of hESCs, which can mimic spatial cell fate patterning during embryonic development. For example, Bauwens et al. used microcontact printing to specify the size of embryoid bodies (EB) from hESCs and found that the ratio of Gata6 (endoderm-associated marker) to Pax6 (neural-associated marker) expression increased with decreasing colony size [50] . Furthermore, in micropatterned EBs generated from endoderm-based input hESCs (high Gata6/Pax6), higher mesoderm and cardiac induction were observed at larger EB sizes, while neural-biased (low Gata6/ Pax6) input hESCs generated EBs that exhibited higher cardiac induction in smaller EBs. Nazareth et al. subsequently used this technique to develop a high-throughput platform to screen the effects of hPSC (human pluripotent stem cell) colony size and cell density on lineage induction via exogenous developmental factors [51] . In another study, Ma et al. created a platform that when hESCs were exposed to BMP4 and modulation of the WNT/B-catenin pathway, the colonies differentiated into an outer trophectoderm-like ring, an inner ectodermal circle and a ring of mesendoderm [52] ( figure 2a-d) . The biochemical and biophysical cues induced a self-organizing primitive human cardiac microchamber. The cardiac microchambers were used to screen drugs suspected to affect fetal cardiac development. As an example, thalidomide was applied during cardiac differentiation. The drug not only significantly damaged the formation of the microchambers, but also caused reduced contractility and lower differentiation (figure 2e-j).
Spheroids/organoids (a) Liver
Three-dimensional (3D) systems for cell culture applications have gained immense interest for pharmaceutical development and tissue engineering due to their ability to better recapitulate the cell microenvironment and spatial orientation than conventional two-dimensional (2D) monolayers [54] . Many studies have shown that hepatocytes can be stabilized in 3D spheroids, leading to the establishment of homotypic cell-cell and cell-ECM interactions [55] . Hepatocellular functions can be further enhanced via heterotypic interactions with liver-and nonliver-derived NPCs. Hepatic spheroids can spontaneously form on non-treated culture plates or those coated with various polymers [56, 57] . For instance, Bell et al. created spheroids of PHHs and NPCs using ultra-low attachment plates. The spheroids remained phenotypically stable and retained morphology for approximately five weeks of culture. Chronic exposure to hepatotoxic drugs resulted in an increase in hepatocyte 57] . While the spheroids formed using ultra-low attachment plates as discussed above can remain viable long-term, the main complication lies in controlling the spheroid size. When spheroids become too large, the cells residing in the spheroid's centre tend to become necrotic due to poor diffusion of oxygen and nutrients.
; these organoids displayed high viability, albumin secretion and CYP3A4 activity for four weeks, and were more sensitive to trovafloxacin toxicity than monolayers. Finally, Ma et al. bioprinted liver lobule-like hexagonal organoids containing iHeps, endothelial cells, and adiposederived stem cells embedded in a hydrogel, and detected functions at higher levels than monolayers [61] .
The previously mentioned spheroids rely on cell-secreted ECM; however, this approach does not allow for reproducible modulation of the biochemical and biomechanical microenvironment around cells. In comparison, naturally-derived (alginate, chitosan and cellulose) and synthetic biomaterials (polyethylene glycol or PEG) can be used to counteract this limitation by presenting an engineered polymer matrix to the cells [55] . For instance, biocompatible PEG hydrogels allow precise control over mechanical properties through customization of chain length and control over biochemical properties through the tethering of ligands such as cell adhesion peptides and growth factors [62] . Chen et al. co-cultured PHHs, 3T3-J2 murine embryonic fibroblasts, and immortalized liver sinusoidal endothelial cells (LSECs) in PEG hydrogels modified with cell adhesion ligands and observed relatively stable albumin and urea secretion for 8 days in culture. A microfluidic droplet generator was subsequently used to generate PEG-based hepatic microtissues, which are more amenable to high-throughput drug studies than bulk gels [63] . In a study using a naturallyderived biomaterial, Tasnim et al. encapsulated human pluripotent stem cell-derived hepatocyte-like cells in galactosylated cellulosic sponges, which promoted the formation and retention of spheroids [64] ; such spheroids were more sensitive to the toxicity of hepatotoxic drugs as compared to conventional monolayers, and responses in stem cell spheroids were similar to those observed in PHHs.
(b) Heart
Many studies have noted that using multiple cell types from the heart leads to better maturation of iPSC-derived cardiomyocytes (iPSC-CMs). For example, Richards et al. created scaffold-free human cardiac organoids to resemble the developing myocardium through modulating individual cell types [65] . The spheroids were created by using spontaneous aggregation in an agarose hydrogel mould. Human iPSC-CMs, human ventricular cardiac fibroblasts (cFBs) and human umbilical vein endothelial cells (HUVECs) were included to represent/model all cardiac cell types. Ratios of cell types were chosen relative to developing hearts (5 : 4 : 1 iPSC-CM:cFB:HUVEC) as well as relative to adult hearts (3 : 6 : 1 iPSC-CM:cFB:HUVEC). After 10 days in culture, the developing stage ratio showed significantly higher contraction amplitude as compared to the adult combination (100% compared to 50%). Enhanced sarcomere (z-line) formation was observed in the developing heart condition. In another study, Giacomelli et al. incorporated endothelial cells with iPSCCMs in spontaneous aggregates to enhance maturity and pharmacological functions [66] . Microtissues composed of 15% endothelial cells and 85% cardiomyocytes resulted in optimal endothelial cell organization and distribution. The endothelial cells promoted iPSC-CM maturity, as shown by an upregulation of cardiac ion-channel genes and the downregulation of fetal cardiomyocyte-enriched genes.
Microfluidic devices (a) Liver
Perfusion systems, such as organ-on-a-chip technology, allow for automated control over culture medium pH, fluid pressures, nutrient supply, temperature and waste removal. The Griffith group at Massachusetts Institute of Technology established a perfused liver platform for drug screening called the 'LiverChip' [67, 68] . In this device, hepatocyte aggregates can adhere to collagen-coated walls of micro-channels created using silicone or polycarbonate ( figure 1h-j ) . The device is then perfused to meet the oxygen demands of the cells without causing excessive shear stress to the cells to mirror in vivo conditions. The hepatocyte aggregates maintain functions over a magnitude greater under perfusion than the static controls (figure 1k). PHH-Kupffer cell aggregates in the LiverChip have a physiologic response to lipopolysaccharide (LPS, a gut bacterial-derived endotoxin) stimulation through increasing the secretion of 11 different pro-inflammatory cytokines (i.e. IL-6, TNFa, CCL5) [69, 70] . Stimulating these PHH-Kupffer cell aggregates with IL-6 caused a dose-dependent decrease in CYP3A4 activity, an increase in C-reactive protein (CRP) secretion, and a decrease in shed soluble IL-6-receptor (IL-6R) levels, which demonstrates an in vivo-like response of PHHs to IL-6 [27] . When the IL-6-stimulated co-cultures were treated with tocilizumab, an anti-IL-6R monoclonal antibody, there was a dramatic recovery of CYP3A4 activity and a reduction in CRP levels after 72 h of treatment.
Other groups have used PDMS-based microfluidic devices to perfuse liver co-cultures for drug screening. PDMS is biocompatible, transparent, and allows for rapid prototyping capabilities. For instance, Novik et al. showed that production of drug metabolites was observed at a greater rate in perfused PHH-endothelial co-cultures relative to static controls [71] . Similarly, Esch et al. found higher albumin and urea secretions in perfused co-cultures of PHHs and a liver NPC mixture (fibroblasts, HSCs and Kupffer cells) as compared to static controls [72] . For routine drug screening applications, however, hydrophobic and porous PDMS can soak in some highly lipophilic drugs; thus, thermoplastic-based alternatives are being explored for the next generation of microfluidic cell culture devices that can mitigate such a limitation [73] .
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Perfusion systems can also subject the cells to gradients of oxygen, nutrients and hormones, which have been shown to recapitulate zonation or differential functions in hepatocytes across the length of the sinusoid [74, 75] . DILI can also be consistent with a certain zonated pattern depending on the mechanism of action of the drug and its metabolism by specific isoenzymes in the hepatocytes [76, 77] . For example, Allen et al. described a parallel-plate bioreactor with oxygen gradients that was used to induce an in vivo-like zonated pattern of CYP450s and acetaminophen toxicity in rat hepatocyte cultures [78] and hepatocyte-fibroblast co-cultures [79] . More recently, layered human hepatocyte-NPC co-cultures were subjected to zone 1 oxygen (10-12%) or zone 3 oxygen (3-5%) levels via variable culture medium perfusion rates in separate devices [80] . Zone 1 co-cultures exhibited greater levels of oxidative phosphorylation, albumin secretion and urea synthesis as compared to zone 3 co-cultures, while zone 3 co-cultures exhibited greater levels of alpha-1-antitrypsin activity, glycolysis, steatosis, CYP2E1 activity and acetaminophen toxicity as compared to zone 1 co-cultures; these findings are consistent with known zonation outcomes in vivo. In contrast to an oxygen gradient, McCarty et al. engineered a gradient of soluble factors (i.e. hormones and drugs) onto a rat hepatocyte monolayer using a microfluidic device [81] . By subjecting the cells to glucagon and insulin gradients, the cells contained less cytoplasmic glycogen when exposed to high levels of glucagon and more glycogen when exposed to high insulin levels. Furthermore, cultures that were subjected to a gradient of 3-methylcholanthrene (3-MC), an inducer of glutathione S-transferase and CYP450 enzymes, displayed greater hepatotoxicity of allyl alcohol in the low 3-MC region and greater hepatotoxicity of acetaminophen in the high 3-MC region.
(b) Heart
Miniaturized microphysiological systems (MPS) are being fabricated to allow precise control over microenvironments, increase reproducibility of experiments, and elevate cell function. To increase the accuracy of drug-induced cardiotoxicity predictions, Mathur et al. proposed a MPS to recapitulate the human myocardium [53] . Isoproterenol (beta-adrenergic agonist), E-4031 (hERG blocker), verapamil (multi-ion channel blocker) and metoprolol (beta-adrenergic antagonist) were chosen to validate the system as they represent four classes of pharmacological agents. The MPS maintained greater similarities to measurements obtained from human ventricular heart slices and significantly higher values than conventional 2D iPSC-CM cultures ( figure 2k-n) . The MPS shows potential to supplement animal models to recreate in vivo-like cardiotoxicity.
It is essential to evaluate the effect of drugs on ion channels as well as monitor cardiomyocyte mechanical contraction status. While many in vitro methods have been created to detect electrophysiological properties, such as patch clamping, current platforms are being engineered to address cardiomyocyte mechanical contraction. Zhang et al. designed a device to evaluate drug efficacy by using high-speed impedance detection technology [82] . Interdigitated electrodes (IDEs) were integrated into quartz using electron beam lithography and a polystyrene chamber was affixed on top for the culture of cells. Primary neonatal rat cardiomyocytes rhythmically contracted and relaxed after being cultured atop the IDEs for 1-2 days. The cardiomyocytes were subjected to different drugs and the beating rate and contractility were monitored. For example, when verapamil, a class IV antiarrhythmic drug used as an L-type calcium channel blocker, was introduced to the cells, beating rates decreased from 114.9 + 2.1 to 44.9 + 1.1 and 23.2 + 6.6 beats per minute with 62.5 nM and 125 nM verapamil, respectively. In another study, Marsano et al. created a microfluidic device that included an array of hanging posts that confined gels containing cells, and a pneumatic actuation system to induce homogeneous uniaxial cyclic strains in the cultures [83] . The authors aimed to recapitulate a native myocardium environment by subjecting human iPSC-CMs to a pacing signal consisting of a square pulse (4 ms duration) with a tunable frequency (1-10 Hz) and an amplitude of 0-23 V. Indeed, the stimulated microtissues displayed greater electrical and mechanical coupling relative to the controls, and responded appropriately to isoprenaline (a beta-1-and beta-2-adrenoceptor agonist) with a positive chronotopic effect (i.e. increase in contraction frequency).
Conclusion and future outlook
In contrast to conventional 2D monolayers, sophisticated engineering tools such as micropatterning, microfluidics, specialized plates, biomaterials scaffolds, and 3D bioprinting allow more precise control over the cell microenvironment, which has led to stable tissue (i.e. liver and heart) function for several weeks. Such longevity of functions has proven highly useful for chronic treatment with drugs and other stimuli (i.e. viruses and cell differentiation cues) to significantly enhance the sensitivity for the prediction of clinical outcomes as compared to short-term (less than 24 h) treatment of cell monolayers.
While many of the techniques examined above are considerably higher throughput than live animal testing or organ slices, they are currently incapable of testing thousands of compounds for drug toxicity or efficacy in a rapid screening campaign, largely due to either the use of limited (and often expensive) primary cells and/or microfluidic perfusion in a few devices at a time. Thus, the pharmaceutical industry continues to rely on cancerous or immortalized cell line-based mono-cultures in multi-well plates (e.g. 384-well tissue culture polystyrene plates) to screen out the most problematic (e.g. toxic) compounds in the early stages of drug development at a significantly reduced cost prior to proceeding with testing a few dozen compounds in more advanced/complex/ expensive engineered culture platforms. An advanced technology that may eventually be adapted for high-throughput screening is a cellular microarray in which the cells are micropatterned onto spotted biomolecules (e.g. extracellular matrix proteins) in a glass slide layout amenable to automated high content imaging [84] [85] [86] . The cells on such microarrays can be further incubated with spotted drugs to create thousands of incubation conditions on a given slide. However, so far the utility of such cell microarrays has been restricted to cancerous human cell lines or animal-derived primary cells. We anticipate that the use of cell microarrays for the culture of human cells, primary and iPSC-derived, will continue to grow and they will also serve to further elucidate combinatorial microenvironmental conditions that can keep primary cells highly functional in vitro. Lastly, the growing use of iPSC-derived cells in advanced culture formats (e.g. 96-well rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 373: 20170225 It is not currently possible to predict with in vitro approaches which specific individuals will adapt to cell stress and which individual will experience progressive and severe DILI or cardiotoxicity. The differentiation of iPSCs from thousands of human patients with different genetic backgrounds into multiple types of liver and heart cells may potentially be beneficial for elucidating inter-individual variations in DILI or cardiotoxicity outcomes [42, 87] . While advanced engineered platforms have greatly impacted the maturity of iPSCs for both liver and cardiac engineering, they do not entirely recapitulate native cell types. Thus, for iPSC engineered platforms to be fully adapted for pharmaceutical applications, further research is required; it has been suggested that a physiologically-based microenvironment is necessary for further maturation [88, 89] , considering both genetic and environmental factors.
In conclusion, bioengineered liver and heart models of increasing cellular and technological complexities are available for investigating cell responses to drugs and other stimuli based on the posed hypotheses and throughput requirements (table 1). We anticipate that the ongoing development of more sophisticated engineering tools for manipulating cells in culture will lead to continual advances in bioengineered livers and hearts that display improving sensitivity for the prediction of clinically relevant drug and disease outcomes. Such an outcome will undoubtedly help mitigate the risk of druginduced liver and cardiotoxicity in human patient populations and concomitantly reduce the use of animals for preclinical drug testing. 
